Decreasing Nightmares in Adults With Narcolepsy
Imagery Rehearsal Therapy for the Treatment of Nightmares in Narcolepsy: A Pilot Randomized Controlled Trial
University of Utah
80 participants
Jul 1, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Eligibility
Inclusion Criteria11
- PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES
- Diagnosis of narcolepsy type 1 or narcolepsy type 2
- Nightmare frequency of ≥1 times per week
- Age 18 or older
- Able to speak, read, and write in English
- Live in the United States
- Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study
- Live with a romantic partner who meets the above criteria and has agreed to participate in the study
- Age 18 or older
- Able to speak, read, and write in English
- Live in the United States
Exclusion Criteria5
- Currently engaged in trauma- or sleep-related psychotherapy
- Previous behavioral treatment for nightmares
- Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
- Untreated moderate-severe sleep apnea
- PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. During the sessions, participants will learn techniques for managing and changing nightmares.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06383806